Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, since the middle of the week is already here, which means there is much to do. No doubt, you can relate on some level. Of course, this also means that we are edging closer to another weekend. So please join us as we grab a cup of stimulation – our choice today is glazed doughnut – and tackle the online calls and deadlines that are piling up. Meanwhile, here is the latest grab of items of interest to help you along. Hope you conquer the world today and do stay in touch…

Robert Califf escaped largely unscathed from a two-hour hearing vetting him to be U.S. Food and Drug Administration commissioner, STAT tells us. He gushed about his love of high-quality data, skillfully navigated questions on hot-button topics like abortion and drug pricing, and even had personal anecdotes about Covid-19 testing and opioid prescribing at the ready. His only stumble came when he clearly frustrated lawmakers with his responses to pointed questions about the FDA’s approach toward approving opioid drugs, including its general reluctance to crack down on long-term prescribing of opioids and its recent decisions to approve new high-dose opioids.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment